| Metric | შპს ანშენ ფარმა | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾1.8m₾2.2m | ₾2.11bn₾1.93bn |
| Revenue growth | -15.9% | 9.5% |
| Profitability | ||
| EBITDA | ₾611k₾355k | — |
| EBITDA margin | 33.4%16.3% | — |
| Net profit | ₾520k₾288k | ₾1.12bn₾1.02bn |
| Net margin | 28.4%13.2% | 53.0%53.1% |
| Balance sheet | ||
| Total assets | ₾2.7m₾2.3m | ₾31.77bn₾28.33bn |
| Total equity | ₾2.7m₾2.2m | ₾4.75bn₾4.27bn |
| ROE | 19.2%13.1% | 23.6%24.0% |